Chitin/PLGA blend microspheres as a biodegradable drug delivery system: A new delivery system for protein

Biomaterials

Volumn 24, Issue 27, 2003, Pages 5023-5036

  Mi, Fwu Long ^a   Shyu, Shin Shing ^b   Lin, Yi Mei ^c   Wu, Yu Bey ^c   Peng, Chih Kang ^c   Tsai, Yi Hung ^d  

^a Chinese Naval Academy Kaohsiung   (Taiwan)

^b VAN NUNG INSTITUTE OF TECHNOLOGY   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Biodegradable; Chitin; Drug delivery; Microsphere; Phase separation; PLGA 50 50

Indexed keywords

BIODEGRADATION; DRUG PRODUCTS; HYDRATION; POLYMER BLENDS; SOLVENTS;

MICROSPHERES;

PROTEINS;

BOVINE SERUM ALBUMIN; CHITIN; MICROSPHERE; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; POLYMER; PROTEIN; SOLVENT; WATER;

ARTICLE; BIODEGRADABILITY; CHEMICAL PARAMETERS; CONTROLLED DRUG RELEASE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; EXPERIMENTAL MODEL; HYDRATION; METHODOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; SLOW DRUG RELEASE; THERMODYNAMICS; TIMED DRUG RELEASE; WATER TEMPERATURE;

BOVINAE;

EID: 0141961726     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00413-7     Document Type: Article

References (35)

1. Carrasquillo K.G., Stanely A.M., Aponte-Carro J.C., J'esus P.D., Costantino H.R., Bosques C.J., Griebenow K. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J Control Rel. 76:2001;199-208.
2. Hurrell S., Cameron R.E. The effect of initial polymer morphology on the degradation and drug release from polyglycolide. Biomaterials. 23:2002;2401-2409.
3. Qian F., Nasongkla N., Gao J. Membrane-encased polymer millirods for sustained release of 5-fluorouracil. J Biomedical Mater Res. 61:2002;203-211.
4. Huatan H., Collett J.H., Attwood D., Booth C. Preparation and characterization of poly(ε-caprolactone) polymer blends for the delivery of proteins. Biomaterials. 16:1995;1297-1303.
5. Mamouzelos N.J., Proikakis C.S., Tarantili P.A., Andreopoulos A.G. Release of propranolol and diclofenac from low Mw DL-poly(lactic acid). J Biomater Appl. 16:2002;177-190.
6. Sturesson C., Carlfors J. Incorporation of protein in PLG-microspheres with retention of bioactivity. J Control Rel. 67:2000;171-178.
7. Lee S.J., Park Y.J., Park S.N., Lee Y.M., Seol Y.J., Ku, Y, Chung C.P. Molded porous poly(L-Lactide) membranes for guided bone regeneration with enhanced effects by controlled growth factor release. J Biomedical Mater Res. 55:2001;295-303.
8. Eliaz R.E., Kost J. Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins. J Biomedical Mater Res. 50:2000;388-396.
9. Park T.G. Degradation of poly(lactic-co-glycolic acid) microspheres. effect of copolymer composition Biomaterials. 16:1995;1123-1130.
10. Holy C.E., Dang S.M., Davies J.E., Shoichet M.S. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam. Biomaterials. 20:1999;1177-1185.
11. Lu L., Peter S.J., Lyman M.D., Lai H.L., Leite S.M., Tamada J.A., Uyama S., Vacanti J.P., Langer R., Mikos A.G. In vitro and in vivo degradation of porous poly(DL-lactide-co-glycolide) foam. Biomaterials. 21:2000;1837-1845.
12. Lu L., Garcia C.A., Mikos A.G. In vitro degradation of thin poly(DL-lactide-co-glycolic acid) films. J Biomed Mater Res. 46:1999;236-244.
13. O'Hagan D.T., Jeffery H., Davis S.S. The preparation and characterization of poly(lactide-co-glycolide) microparticles - III. microparticle/polymer degradation rates and the in vitro release of a model protein J Control Rel. 103:1994;37-45.
14. Park T.C., Cohen S., Langer R. Poly(L-lactic acid)/pluronic blends. characterization of phase separation behavior, degradation, and morphology and use as protein-releasing matrices Macromolecules. 25:1992;116-122.
15. Ibim S.E.M., Ambrosio A.M.A., Kwon M.S., El-Amin S.F., Allcock H.R., Laurencin C.T. Novel polyphosphazene/poly(lactide-co-glycolide) blends. miscibility and degradation studies Biomaterials. 18:1997;1565-1569.
16. Pitt C.G., Cha Y., Shah S.S., Zhu K.J. Blends of PVA and PLGA. control of the permeability and degradability of hydrogels by blending J Control Rel. 19:1992;189-200.
17. Biodegradable poly(D,L-lactic acid acid)-poly(ethylene glycol) -monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials. Biomaterials 2000;21:2361-70.
18. Hata H., Onishi H., Machida Y. Preparation of CM-chitin microspheres by complexation with iron(III) in w/o emulsion and their biodisposition characteristics in mice. Biomaterials. 21:2000;1779-1788.
19. Nsereko S., Amiji M. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations. Biomaterials. 23:2002;2723-2731.
20. Cao X., Shoichet M.S. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials. 20:1999;329-339.
21. Kim T.H., Lee H., Park T.G. Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. Biomaterials. 23:2002;2311-2317.
22. King T.W., Patrick C.W. Jr. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J Biomed Mater Res. 51:2000;383-390.
23. Meinel L., Illi O.E., Zapf J., Malfanti M., Merkle H.P., Gander B. Stabilizing insuin-like growth factor-I in poly(DL-lactic-co-glycolic acid) microspheres. J Control Rel. 70:2001;193-202.
24. Kohn J., Niemi S.M., Albert E.C., Murphy J.C., Langer R., Fox J.F. Single-step immunization using a controlled reklease, biodegradable polymer with sustained adjuvant activity. J Immunol Methods. 95:1986;31-38.
25. Morris W, Steinhoff MC, Russell PK. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 1994;12:5-11.
26. Webber W.L., Lago F., Thanos C., Mathiowitz E. Resorbable lamellar particles of polylactide as adjuvants for influenza vaccines. Biomaterials. 19:1998;1073-1081.
27. Dunne M., Corrigan O.I., Ramtoola Z. Biodegradable polymeric microparticles for drug delivery and vaccine formulation. the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments Biomaterials. 18:1997;1153-1161.
28. Lee H.K., Park J.H., Kwon K.C. Double-wall microparticles for single shot vaccine. J Control Rel. 44:1997;283-293.
29. Lai J.Y., Lin F.C., Wang C.C., Wang D.M. Effect of nonsolvent additives on the porosity and morphology of asymmetric TPX membranes. J Membr Sci. 118:1996;49-54.
30. Grulke, E. A. Solubility of parameter values. In: Brandrup J, Immergut EH, editors. Polymer Handbook. New York: Wiley; 1989. p. 44: 525-32.
31. Gogolewski S., Mainil-Varlet P. Effect of thermal treatment on sterility, molecular and mechanical properties of various polylactides. Biomaterials. 18:1997;251-255.
32. Mi F.L., Lin Y.M., Wu Y.B., Shyu S.S., Tsai Y.H. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system. phase-separation, degradation and release behavior Biomaterials. 23:2002;3257-3267.
33. Kim H.K., Park T.G. Microencapsulation of human growth hormone within biodegradable polyester microspheres. protein aggregation stability and incomplete release mechanism Biotechnol Bioeng. 65:1999;659-667.
34. Wang F., Lee T., Wang C.H. PEG modulated release of etanidazole from implantable PLGA/PDLA discs. Biomaterials. 23:2002;3555-3566.
35. Lu W., Park T.G. Protein release from poly(lactic-co-glycolic acid) microspheres. protein stability problems J Pharm Sci Technol. 49:1995;13-19.